Allan Camaisa
CIK: 0001990674
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (66.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CLDI
Calidi Biotherapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Dec 12, 2025CLDI
Calidi Biotherapeutics, Inc.
Sale(S)Indirect850 shares at avg. $1.46$1K - Dec 17, 2024CLDI
Calidi Biotherapeutics, Inc.
Sale(S)Direct10K shares at avg. $1.62$16K - Sep 26, 2024CLDI
Calidi Biotherapeutics, Inc.
Award(A)Direct70.2K shares at avg. $1.15$81K
1-3 of 3 transactions
About Camaisa Allan
Camaisa Allan (SEC CIK 0001990674) files insider reports with the SEC as CEO and Chairman of the Board of Calidi Biotherapeutics, Inc. (CLDI).
Signal8 holds 3 ownership filings by Camaisa Allan, all Form 4s, filed between Sep 30, 2024 and Dec 16, 2025. Those filings report 3 transactions, from Sep 26, 2024 to Dec 12, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Camaisa Allan's filings is in SAN DIEGO,, CA.
Recent filings by Camaisa Allan
Other insiders filing for Calidi Biotherapeutics, Inc. (CLDI)
- Peoples George, Director
- Leftwich Scott, Director
- Stewart Alan R., Director
- Jackson Andrew C., Chief Financial Officer
- Schoeneck James A, Director
- Poma Eric E, Chief Executive Officer